Mechanical Engineer I

Join the Future of Robotic Biomanufacturing! Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics - including cell therapies, gene therapies, mRNA therapies, and more. Currently, advanced biological therapies are produced through manual, labor-intensive processes. This keeps costs astronomical—often exceeding $0.5M-$2M per patient—and limits access to only a fraction of those in need.  As labor scarcity for scientists compound against increased product complexity and sky-high costs of failure, the emergence of robotics and AI makes the automated manufacturing of biologics feasible, reliable, and economically scalable.  We envision that the biomanufacturing factory of the future is fully robotic - closed, automated, and scalable, making therapeutics for some of the most important indications for patients today widely accessible.   Why This Matters We don’t just build robots; we build the infrastructure for the next generation of biologics manufacturing. Our technology allows biopharma companies to scale production without redesigning their science, drastically lowering regulatory hurdles and bringing costs down to a level where these treatments can actually reach patients. The Stack & The Scale The Mission: Build the world’s best robots to make life-saving therapies accessible to all. The Technology: Advanced robotic orchestration, high-precision automation, cloud-integrated hardware-software systems, dextrous manipulation, and imitation learning. The Location: Headquartered in San Francisco, CA. The Backing: Supported by premier investors, including Casdin Capital, Lux Capital, and Y Combinator.